Skip to content
Medical Health Aged Care

Dementia Australia supports Merredin, Narembeen, Bruce Rock and Kellerberrin, WA

Dementia Australia 2 mins read

Are you concerned about your memory or worried that someone you know may have dementia? Dementia Australia is offering support in Merredin, Narembeen, Bruce Rock and Kellerberrin, WA between 27 t0 30 October, 2025. 

 

It is estimated there are 42,000 people living with dementia in WA. Without a medical breakthrough this number is expected to increase to 87,000 people living with dementia by 2054. 

 

The Dementia Australia sessions are an opportunity for people living with dementia, their carers, family, and friends to attend free education to better understand dementia and to discuss the support and services Dementia Australia can provide. Please note, bookings are essential. 

 

Worried About Your Memory? 
This session provides information on memory and common changes that may occur with ageing. It provides strategies for improving memory, when to seek help about your concerns and services provided by Dementia Australia. 
Monday 27 October, 2025, 2pm-4pm AWST, Narembeen 

 
Understanding Changes in Behaviour 
This session provides an introduction to dementia and changes to the brain, effects on behaviour and the impacts of changed behaviour. It will introduce problem solving models, including strategies to minimise and respond to changed behaviour. 
Tuesday 28 October, 2025, 10am-1pm AWST, Merredin 
 

Understanding Dementia  

This session provides an introduction to dementia including an overview of different types of dementia, diagnosis, planning ahead and how to support someone living with dementia.  
Wednesday 29 October, 2025, 10am-12:30pm AWST, Bruce Rock 
 

Worried About Your Memory? 
This session provides information on memory and common changes that may occur with ageing. It provides strategies for improving memory, when to seek help about your concerns and services provided by Dementia Australia. 
Thursday 30 October, 2025, 10am-12pm AWST, Merredin 

 
Communications and Dementia  
The session provides information on dementia, the way we communicate and how changes in communication can occur as a result of dementia. 
Friday 31 October, 2025, 10am-12:30pm AWST, Kellerberrin 

 

 

Bookings are essential. Visit https://www.dementia.org.au/get-involved/brain-hub/brain-hub-merredin-narembeen-bruce-rock-and-kellerberrin-wa for details and to register. You can also call the National Dementia Helpline to register for this course on 1800 100 500. The National Dementia Helpline is available 24 hours a day, seven days a week. 

 

-Ends- 

 

Dementia Australia is the source of trusted information, education and services for the estimated 433,300 Australians living with dementia, and the estimated 1.7 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you. 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au  

Media contacts: David Gear, [email protected], 0435 515 221 

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines. 

Note to Editors: We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:  

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.  

More from this category

  • Medical Health Aged Care
  • 08/12/2025
  • 10:11
BeOne Medicines Ltd.

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid…

  • Contains:
  • Medical Health Aged Care
  • 08/12/2025
  • 09:40
Miltenyi Biomedicine

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease featuresA 12-day manufacturing time resulted in a vein-to-vein time of 14-16 days, reducing the likelihood for bridging therapy.BERGISCH GLADBACH, Germany, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Miltenyi Biomedicine today announced results from the pivotal DALY 2-EU trial evaluating the efficacy and safety of zamtocabtagene autoleucel (zamto-cel) compared with standard chemoimmunotherapy (R-GemOx or Pola-BR) in patients with…

  • Medical Health Aged Care, Seniors Interest
  • 08/12/2025
  • 08:56
Monash University

Men and women may need different medications to avoid broken bones

A new international study, published in Osteoporosis International and led by Monash’s Centre for Medicine Use and Safety (CMUS), investigated the risks of a…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.